Faricimab: current evidence for the treatment of retinal vein occlusion. [PDF]
Vitiello L +10 more
europepmc +1 more source
Letter to the Editor Regarding "Aflibercept 8 mg versus Faricimab Treat-and-Extend for Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration: A Bayesian Fixed-Effect Network Meta-analysis of Clinical Trials". [PDF]
Panos GD.
europepmc +1 more source
Differential Remodeling of the Macular Neovascular Network under Different Anti-VEGF Agents in Age-Related Macular Degeneration. [PDF]
Crincoli E +14 more
europepmc +1 more source
Clinical evaluation of faricimab in real-world neovascular age-related macular degeneration in India: a multicenter observational study. [PDF]
Chakraborty D +7 more
europepmc +1 more source
Effects of vascular endothelial growth factor and angiopoietin-2 inhibitions on intraretinal hyperreflective foci in neovascular age-related macular degeneration. [PDF]
Nakanishi Y +16 more
europepmc +1 more source
Advances in Polypoidal Choroidal Vasculopathy (PCV) Management: Emerging Evidence for Faricimab and Aflibercept 8 mg. [PDF]
Sherif MZ +6 more
europepmc +1 more source
Baseline Biomarkers Associated with Early Anatomical Response After Faricimab Loading Therapy in Treatment-Naïve Neovascular Age-Related Macular Degeneration. [PDF]
Ikeuchi E +4 more
europepmc +1 more source

